SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-007387
Filing Date
2015-11-02
Accepted
2015-11-02 17:00:19
Documents
2
Period of Report
2015-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1596
2 EX-24 DOCUMENT attachment1.htm EX-24 5258
  Complete submission text file 0000899243-15-007387.txt   8214
Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2066960703
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 307 WESTLAKE AVE. NORTH, STE 300 SEATTLE WA 98109
Business Address
Azelby Robert (Reporting) CIK: 0001656998 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36781 | Film No.: 151191286